[en] Oncological imaging is a subspecialty of medical imaging and focuses on the workup and the follow-up of cancer. Oncological imaging takes into account all the specificities of cancer diseases, which is a constantly evolving field, especially in the era of precision medicine, and plays a key role in the care of cancer patients. It permits reliable diagnosis and gives precious information concerning disease extension at diagnosis, which is essential for the treatment planning. Oncological imaging allows also followup of patients under treatment, using response evaluation scores. Interventional imaging, which provides minimally invasive procedures, is useful in order to obtain a histological diagnosis, to treat some tumour or to improve quality of life of cancer patients. Finally, numerous perspectives, among them the advent of artificial intelligence (radiomics), will further strengthen the role of oncologic imaging in the near future.
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Cousin, François ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
VALKENBORGH, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
Hustinx, Roland ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Language :
French
Title :
Concepts d’imagerie médicale dans la mise au point et le suivi des cancers : regard sur l’imagerie oncologique.
Alternative titles :
[en] Concepts of medical imaging in the work up and follow-up of cancer : oncological imaging at a glance.
Publication date :
May 2021
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Be
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;caac.21660.
Brady AP. Error and discrepancy in radiology: inevitable or avoidable? Insights Imaging 2017;8:171-82.
Rosenkrantz AB, Mendiratta-Lala M, Bartholmai BJ, et al. Clinical utility of quantitative imaging. Acad Radiol 2015;22:33-49.
Vargas AJ, Harris CC. Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer 2016;1:525-37.
Hersberger KE, Mendiratta-Lala M, Fischer R, et al. Quantitative imaging assessment for clinical trials in oncology. J Natl Compr Canc Netw 2019;17:1505-11.
European Society of Radiology, deSouza NM, Achten E, et al. Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR). Insights Imaging 2019;10:87.
Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging-reporting and data system: 2015, version 2. Eur Urol 2016;69:16-40.
Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018;378:1767-77.
Mottet N, van den Bergh RC, Briers E, et al. EAU-EANMESTRO-ESUR-SIOG Guidelines on prostate cancer. 2020 Update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 2021;79:243-62.
Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018. Practice guidance by the American Association for the study of liver diseases: Marrero et al. Hepatology 2018;68:723-50.
van der Pol CB, Lim CS, Sirlin CB, et al. Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy. A systematic review. Gastroenterology 2019;156:976-86.
Chernyak V, Fowler KJ, Kamaya A, et al. Liver imaging reporting and data system (LI-RADS) Version 2018: Imaging of hepatocellular carcinoma in at-risk patients. Radiology 2018;289:816-30.
James D. Brierley, Mary K. Gospodarowick and christian witterkind. TNM classification of malignant tumours. 8th edition. John Wiley&Sons;2017.
Adam IJ, Martin IG, Finan P, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
Taylor FG, Quirke P, Heald RJ, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol 2014;32:34-43.
Beets-Tan RG, Lambregts DM, Maas M, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018;28:1465-75.
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47.
Tirkes T, Hollar MA, Tann M. Response criteria in oncologic imaging: review of traditional and new criteria. RadioGraphics 2013;33:1323-41.
Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23.
Nishino M, Hatabu H, Hodi FS. Imaging of cancer immunotherapy: current approaches and future directions. Radiology 2019;290:9-22.
Park HJ, Kim KW, Pyo J, et al. Incidence of pseudoprogression during immune checkpoint inhibitor therapy for solid tumors: a systematic review and meta-analysis. Radiology 2020;297:87-96.
Michot JM, Bigenwald C, Champiat S, et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 2016;54:139-48.
Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology 2016;278:563-77.
Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014;5:4006.
Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 2012;48:441-6.
Dhara AK. A combination of shape and texture features for classification of pulmonary nodules in lung CT images. J Digit Imaging 2016;29:466-7.
Yoon HJ, Sohn I, Cho JH, et al. Decoding tumor phenotypes for ALK, ROS1, and RET fusions in lung adenocarcinoma using a radiomics approach. Medicine (Baltimore) 2015;94:e1753.
